Global Peptide API CDMO Services Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Peptide API CDMO Services market size will reach 2,940.82 Million USD in 2025 and is projected to reach 7,723.19 Million USD by 2032, with a CAGR of 14.79% (2025-2032). Notably, the China Peptide API CDMO Services market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peptide API CDMO (Contract Development and Manufacturing Organization) services involve the synthesis, development, and production of peptide Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies. These services encompass the entire process of peptide drug development, from initial research and design to commercial-scale manufacturing. CDMOs specializing in peptide APIs offer expertise in peptide chemistry, process optimization, analytical methods development, and regulatory compliance. They assist pharmaceutical companies in custom synthesis of peptides, process scale-up, formulation development, and manufacturing of high-quality peptide APIs for clinical trials and commercialization. Peptide API CDMO services provide pharmaceutical companies with the flexibility, efficiency, and expertise needed to accelerate drug development timelines and bring peptide-based therapeutics to market.
The major global suppliers of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide API CDMO Services. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide API CDMO Services market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Peptide API CDMO Services market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide API CDMO Services industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide API CDMO Services Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide API CDMO Services Product Segment Include:
GMP Services
Non-GMP Services
Peptide API CDMO Services Product Application Include:
Commercial
Scientific Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Peptide API CDMO Services Industry PESTEL Analysis
Chapter 3: Global Peptide API CDMO Services Industry Porter's Five Forces Analysis
Chapter 4: Global Peptide API CDMO Services Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Peptide API CDMO Services Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Peptide API CDMO Services Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Peptide API CDMO Services Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Peptide API CDMO Services market size will reach 2,940.82 Million USD in 2025 and is projected to reach 7,723.19 Million USD by 2032, with a CAGR of 14.79% (2025-2032). Notably, the China Peptide API CDMO Services market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peptide API CDMO (Contract Development and Manufacturing Organization) services involve the synthesis, development, and production of peptide Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies. These services encompass the entire process of peptide drug development, from initial research and design to commercial-scale manufacturing. CDMOs specializing in peptide APIs offer expertise in peptide chemistry, process optimization, analytical methods development, and regulatory compliance. They assist pharmaceutical companies in custom synthesis of peptides, process scale-up, formulation development, and manufacturing of high-quality peptide APIs for clinical trials and commercialization. Peptide API CDMO services provide pharmaceutical companies with the flexibility, efficiency, and expertise needed to accelerate drug development timelines and bring peptide-based therapeutics to market.
The major global suppliers of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide API CDMO Services. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide API CDMO Services market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Peptide API CDMO Services market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide API CDMO Services industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide API CDMO Services Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide API CDMO Services Product Segment Include:
GMP Services
Non-GMP Services
Peptide API CDMO Services Product Application Include:
Commercial
Scientific Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Peptide API CDMO Services Industry PESTEL Analysis
Chapter 3: Global Peptide API CDMO Services Industry Porter's Five Forces Analysis
Chapter 4: Global Peptide API CDMO Services Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Peptide API CDMO Services Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Peptide API CDMO Services Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Peptide API CDMO Services Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Peptide API CDMO Services Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peptide API CDMO Services Product by Type
- 1.2.1 GMP Services
- 1.2.2 Non-GMP Services
- 1.3 Peptide API CDMO Services Product by Application
- 1.3.1 Commercial
- 1.3.2 Scientific Research
- 1.3.3 Other
- 1.4 Global Peptide API CDMO Services Market Size Analysis (2020-2032)
- 1.5 Peptide API CDMO Services Market Development Status and Trends
- 1.5.1 Peptide API CDMO Services Industry Development Status Analysis
- 1.5.2 Peptide API CDMO Services Industry Development Trends Analysis
- 2 Peptide API CDMO Services Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peptide API CDMO Services Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peptide API CDMO Services Market Analysis by Country
- 4.1 Global Peptide API CDMO Services Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Peptide API CDMO Services Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Peptide API CDMO Services Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.5 China Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.6 France Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.14 India Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Peptide API CDMO Services Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Peptide API CDMO Services Market Revenue by Key Suppliers (2021-2025)
- 5.2 Peptide API CDMO Services Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Peptide API CDMO Services Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Peptide API CDMO Services Market Analysis by Type
- 6.1 Global Peptide API CDMO Services Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Peptide API CDMO Services Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Bachem
- 7.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Bachem Peptide API CDMO Services Product Portfolio
- 7.1.3 Bachem Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 PolyPeptide
- 7.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 PolyPeptide Peptide API CDMO Services Product Portfolio
- 7.2.3 PolyPeptide Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 CordenPharma
- 7.3.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 CordenPharma Peptide API CDMO Services Product Portfolio
- 7.3.3 CordenPharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 AmbioPharm
- 7.4.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 AmbioPharm Peptide API CDMO Services Product Portfolio
- 7.4.3 AmbioPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 USV Peptides
- 7.5.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 USV Peptides Peptide API CDMO Services Product Portfolio
- 7.5.3 USV Peptides Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Thermofischer
- 7.6.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Thermofischer Peptide API CDMO Services Product Portfolio
- 7.6.3 Thermofischer Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Bio Basic
- 7.7.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bio Basic Peptide API CDMO Services Product Portfolio
- 7.7.3 Bio Basic Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 JPT
- 7.8.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 JPT Peptide API CDMO Services Product Portfolio
- 7.8.3 JPT Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Genscript
- 7.9.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Genscript Peptide API CDMO Services Product Portfolio
- 7.9.3 Genscript Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Xinbang Pharma
- 7.10.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Xinbang Pharma Peptide API CDMO Services Product Portfolio
- 7.10.3 Xinbang Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 ScinoPharm
- 7.11.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 ScinoPharm Peptide API CDMO Services Product Portfolio
- 7.11.3 ScinoPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 SN Biopharm
- 7.12.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 SN Biopharm Peptide API CDMO Services Product Portfolio
- 7.12.3 SN Biopharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 CBL
- 7.13.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 CBL Peptide API CDMO Services Product Portfolio
- 7.13.3 CBL Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Piramal Pharma
- 7.14.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Piramal Pharma Peptide API CDMO Services Product Portfolio
- 7.14.3 Piramal Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 CPC Scientific
- 7.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 CPC Scientific Peptide API CDMO Services Product Portfolio
- 7.15.3 CPC Scientific Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Peptide API CDMO Services Industry Chain Analysis
- 8.2 Peptide API CDMO Services Product Downstream Application Analysis
- 8.2.1 Global Peptide API CDMO Services Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Peptide API CDMO Services Revenue and Forecast by Application (2020-2032)
- 8.3 Peptide API CDMO Services Typical Downstream Customers
- 8.4 Peptide API CDMO Services Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
